BUSINESSWIRE –
June 23rd – Alnylam Biotherapeutics Presents New Data on RNAi Applications in Biotherapeutics Manufacturing
June 22nd – Isis and Alnylam Provide Update on Regulus’ Strategic Alliance with Sanofi-Aventis
June 22nd – Sanofi-Aventis and Regulus Therapeutics Form Major Strategic Alliance on microRNA Therapeutics
June 3rd – Rosetta Genomics Establishes “Rosetta Green” as Majority-owned Subsidiary
Subscribe to the miRNA blog
Thank you for subscribing.
Something went wrong.
Looks as if we missed one:
June 23rd – Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-Targeted Medicines for the Treatment of Cardiovascular Disease
http://www.prnewswire.com/news-releases/santaris-pharma-as-and-miragen-therapeutics-inc-form-strategic-alliance-to-develop-microrna-targeted-medicines-for-the-treatment-of-cardiovascular-disease-96964249.html
Thanks go to Anna & Bruce for pointing it out!